In a filing, Pulse Biosciences Inc revealed its Chief Technology Officer UECKER DARRIN unloaded Company’s shares for reported $0.25 million on Jun 12 ’25. In the deal valued at $16.40 per share,15,000 shares were sold. As a result of this transaction, UECKER DARRIN now holds 137,872 shares worth roughly $2.07 million.
Then, UECKER DARRIN sold 15,000 shares, generating $239,700 in total proceeds. Upon selling the shares at $15.98, the Chief Technology Officer now owns 122,872 shares.
Before that, DARRIN UECKER bought 15,000 shares. Pulse Biosciences Inc shares valued at $239,740 were divested by the Officer at a price of $15.98 per share.
Stephens initiated its Pulse Biosciences Inc [PLSE] rating to an Overweight in a research note published on July 27, 2021; the price target was $28. A number of analysts have revised their coverage, including Maxim Group’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering PLSE and reiterated its “Buy” recommendation on January 26, 2021. H.C. Wainwright revised its rating on May 12, 2020. It rated PLSE as “a Buy” which previously was an “a Neutral”.
Price Performance Review of PLSE
On Tuesday, Pulse Biosciences Inc [NASDAQ:PLSE] saw its stock fall -1.89% to $15.04. Over the last five days, the stock has lost -13.26%. Pulse Biosciences Inc shares have fallen nearly -13.61% since the year began. Nevertheless, the stocks have risen 23.28% over the past one year. While a 52-week high of $25.00 was reached on 02/05/25, a 52-week low of $9.70 was recorded on 04/04/25.
Levels Of Support And Resistance For PLSE Stock
The 24-hour chart illustrates a support level at 14.74, which if violated will result in even more drops to 14.45. On the upside, there is a resistance level at 15.31. A further resistance level may holdings at 15.59.
